ALPMY
ASTELLAS PHARMA/ADR

319
Mkt Cap
$29.52B
Volume
81,812.00
52W High
$17.35
52W Low
$8.37
PE Ratio
13.70
ALPMY Fundamentals
Price
$16.48
Prev Close
$16.78
Open
$16.24
50D MA
$15.42
Beta
0.27
Avg. Volume
156,676.95
EPS (Annual)
$0.1859
P/B
2.62
Rev/Employee
$919,438.95
$22,390.70
Loading...
Loading...

About

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13,643

Frequently Asked Questions

What is Market Cap of Astellas Pharma Inc. - ADR?
What is the 52-week high for Astellas Pharma Inc. - ADR?
What is the 52-week low for Astellas Pharma Inc. - ADR?
What is Astellas Pharma Inc. - ADR stock price today?
What was Astellas Pharma Inc. - ADR stock price yesterday?
What is the PE ratio of Astellas Pharma Inc. - ADR?
What is the Price-to-Book ratio of Astellas Pharma Inc. - ADR?
What is the 50-day moving average of Astellas Pharma Inc. - ADR?
How many employees does Astellas Pharma Inc. - ADR have?

Latest ALPMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.